Dynamics of drug response informs rational combination regimens.

Dynamics of drug response informs rational combination regimens. Sci Signal. 2019 Aug 20;12(595): Authors: Paudel BB, Quaranta V Abstract Metabolic plasticity in cancer has been linked to the development of drug-tolerant populations. In this issue of Science Signaling, Goldman et al integrate metabolic plasticity with phenotypic state transitions to examine how this reprogramming can be therapeutically exploited. PMID: 31431544 [PubMed - in process]
Source: Science Signaling - Category: Biomedical Science Authors: Tags: Sci Signal Source Type: research